Abstract:Type I interferons (IFNs) play essential roles in establishing and modulating host defense against microbial infection via induction of IFN-stimulated genes (ISGs) through Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling pathway. However, dysregulation of IFNs production and function could also mediate immune pathogenesis such as inflammatory autoimmune diseases and infectious diseases via aberrantly activating inflammatory responses or improperly suppressing microbial controls. Thus, IFN responses need to be tightly regulated to achieve protective immunity against microbial infection while avoiding harmful toxicity caused by improper or prolonged IFN signaling. Multiple levels of cellular and molecular events act in a cooperated manner to regulate IFN responses, in especial, post-translational modification (PTMs) of signaling molecules and epigenetic modification of gene expression programs are two important mechanisms for regulation of IFN signaling and thus critical for orchestrating IFN-mediated host immune response to the complex pathogenic or environmental stimuli. Conventional PTMs such as phosphorylation and polyubiquitylation, as well as numerous other PTMs including acetylation, ISGylation, SUMOylation and methylation have been shown to potently modulate type I IFN signaling transduction via targeting distinct signaling steps or components. Moreover, epigenetic mechanisms, such as histone modification, DNA methylation, non-coding RNAs play critical roles in regulating chromatin structure and function, leading to flexible and dynamic gene expression patterns downstream type I IFN signaling. Herein, we summarize the recent advances in the PTMs and epigenetic mechanisms in regulation of type I IFN signaling and responses. The involvement of dysregulated IFN signaling in inflammatory and autoimmune diseases are also discussed.

Transcriptional control of metabolism by interferon regulatory factors

Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease.

The multiple roles of interferon regulatory factor family in health and disease

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Interferon regulatory factors are transcriptional regulators of adipogenesis

Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.

Regulating IRFs in IFN Driven Disease

The Interferon Regulatory Factors As Novel Potential Targets in the Treatment of Cardiovascular Diseases

The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Interferon Regulatory Factors: New Targets for Intervention of Cardiovascular Diseases

Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges

Transcriptional regulation of adipocyte lipolysis by IRF2BP2

IRF4 is a Key Thermogenic Transcriptional Partner of PGC-1α

Obese Skeletal Muscle-Expressed Interferon Regulatory Factor 4 Transcriptionally Regulates Mitochondrial Branched-Chain Aminotransferase Reprogramming Metabolome

Metabolic regulation of type I interferon production

Interferon Regulatory Factor 3 Constrains IKKβ/NF-κB Signaling to Alleviate Hepatic Steatosis and Insulin Resistance.

The Role of Interferon Regulatory Factors in Liver Diseases

Division of labor between IRF1 and IRF2 in regulating different stages of transcriptional activation in cellular antiviral activities

Transcriptional and Non-Transcriptional Activation, Posttranslational Modifications, and Antiviral Functions of Interferon Regulatory Factor 3 and Viral Antagonism by the SARS-Coronavirus

Interferon Regulatory Factors: A Key to Tumour Immunity

Interferon Regulatory Factor 3,A Pivotal Transcription Factor for Host Antiviral Responses: Interferon Regulatory Factor 3,A Pivotal Transcription Factor for Host Antiviral Responses